Abstract
By using Fab'-enzyme labelled immuno absorbent assay (ELISA) with sensitivity of picogram (10−12g or pg) level, the M-type pyruvate kinase (M-PyK) in plasma was determined in 47 cases of normal healthy adult and 26 cases of hepatocellular carcinoma (HCC) patient. It was found that the upper limits of normal male and female were 1.1 and 1.4 ng/ml (expressed as M2-PyK) respectively. The plasma M-PyK in HCC patients was significant increased to above 5 times of average normal level, the positive rate was about 95%. In 6 cases of subclinical small hepatocarcinoma and 7 cases of HCC patient with normal serum alphafetal protein level, the mean plasma M-PyK value was also increased. Whereas the plasma M-PyK level in acute or chronic hepatitis and other benign diseases were normal. After the HCC being resected, the plasma M-PyK returned to normal, but increased again in the cases of recurrent hepatocarcinoma, suggesting that the increased M-PyK in the plasma of HCC patient was criginated from M2-type PyK in HCC tissue. Therefore, plasma M-PyK may become a new micro-level index of hepatocarcinoma.
Similar content being viewed by others
References
Lo CH, et al. Glycolytic regulation in rat liver and hepatoma. Adv Enzyme Regul 1968; 6:453.
Imamura K, et al. Pyruvate kinase isozyme from rat. Methods Enzymol 1982; 90:150.
Ibsen KH, et al. Interrelationship and function of the pyruvate kinase isozyme and their variants. A review. Cancer Res 1977; 37:341.
Noguchi T, et al. Regulation of rat liver L-type pyruvate kinase mRNA by insulin and fructose. Eur J Biochem 1982; 128:583.
Johnson ML, et al. Concentration of skeletal and cardiac muscle pyruvate kinase determined by specific radioimmunoassay. Biochim Biophy Acta 1980; 611:127.
Imamura K, et al. Studies in pyruvate kinase (PK) deficiency. J Biochem 1973; 74:1165.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jinbo, L., Huili, C. The value of M2-type pyruvate kinase immunoassay in the diagnosis of hepatocarcinoma. Chinese Journal of Cancer Research 3, 58–61 (1991). https://doi.org/10.1007/BF02672093
Issue Date:
DOI: https://doi.org/10.1007/BF02672093